CSL Plasma Inc in Columbus, Ohio was inspected by the Food and Drug Administration (FDA) on July 18 for blood and blood products and received one citation, according to data posted on the FDA’s official website.
The FDA website shows that the company was cited for the following problem: ‘Medical history assessment failed to include factors that make the donor ineligible to donate because of an increased risk for, or evidence of, a relevant transfusion-transmitted infection such as behaviors associated with a relevant transfusion-transmitted infection.’
The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.
The FDA is a government agency that is primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
